Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Says Not to Snort Chocolate Powder

The FDA posted a warning letter to Legal Lean Syrup and Coco Loko for promoting products as alternatives to street drugs.

Coco Loko / Image: LegalLeanStore.com
Coco Loko / Image: LegalLeanStore.com

There are plenty of ways to consume chocolate, but the FDA doesn’t want people snorting it. A recent press announcement from the FDA said the regulator warned marketers and distributers of Legal Lean Syrup and Coco Loko for promoting the products as alternatives to street drugs. According to the warning letter, the companies’ promotional materials suggest their products can be used like cocaine and may pose safety concerns.

Coco Loko contains taurine and guarana, neither of which have been tested for intranasal administration, which can trigger spasms of the vocal cords and induce or exacerbate asthma. An FDA analysis of Legal Lean Syrup found that the product contained the active pharmaceutical ingredient doxylamine, which was not listed on the product labeling. Approved products containing doxylamine carry warnings that they should not be consumed with alcoholic beverages.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?